VOLUME 12, ISSUE 4 / FEBRUARY 2020
FEBRUARY 2020
Development and validation of a UPLC–MS/MS method for simultaneous determination of LBPT and its metabolites in human plasma
- Mengyi Wu
, - Aijing Liu,
- Quankun Zhuang ,
- Ranran Jia,
- Yinping Zhou,
- Yali Liu &
- Hongyun Wang
- Pages:211–220
- Published Online:21 February 2020
Methodology
FEBRUARY 2020
Evaluation of single molecule array digital immunoassay technology to quantitate neurofilament light chain
- Krishna K Midde,
- Alexa Broadnax,
- Brittany Binion,
- Thomas Oglesby,
- Jake Harman,
- Mike Edwards,
- Heather Myler,
- Katie Matys &
- Patrick Bennett
- Pages:221–229
- Published Online:21 February 2020
Methodology
FEBRUARY 2020
Generic MS-based method for the bioanalysis of therapeutic monoclonal antibodies in nonclinical studies
- Noritaka Hashii,
- Yoshiko Tousaka,
- Koji Arai,
- Ryoya Goda,
- Noriko Inoue,
- Kazuyuki Murata,
- Takeshi Okuzono,
- Satomi Sasahara,
- Takuma Shigeyama,
- Hidehisa Tachiki,
- Shinichi Yamane,
- Yoshiro Saito &
- Akiko Ishii-Watabe
- Pages:231–243
- Published Online:24 February 2020
Research Article
FEBRUARY 2020
Confirmatory cut point has limited ability to make accurate classifications in immunogenicity assays
- Robert J Kubiak ,
- Rosalinda HGP Arends,
- Nancy Lee,
- Meina Liang,
- Jianchun Zhang &
- Lorin K Roskos
- Pages:245–256
- Published Online:24 February 2020
Perspective
FEBRUARY 2020
IQ consortium perspective: complementary LBA and LC–MS in protein therapeutics bioanalysis and biotransformation assessment
- Surinder Kaur,
- Kevin P Bateman ,
- Jim Glick,
- Mark Jairaj,
- John F Kellie,
- Jens Sydor &
- Jianing Zeng
- Pages:257–270
- Published Online:25 February 2020